Pay in 4 interest-free payments of $6.07 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
December 20 Product: Vertex Pharmaceuticals Alyftrek Indication: Adults and children aged 6 and up with cystic fibrosis and at least one F508del mutation or another mutation in the CFTR gene that is responsive to the treatment Vertex Pharmaceuticals said Friday the FDA has approved its next cystic fibrosis product Alyftrek, clearing the biotech to market a product designed to improve on Trikafta
The transition should feel complete
In Colorado, many patients say the promise of lower prices can't come soon enough
High prevalence of erectile dysfunction in diabetes: a systematic review and meta-analysis of 145 studies
Staying well hydrated (at least 64 ounces of water per day) helps your body release excess water and supports the metabolic processes involved in fat breakdown
US$ 26.80
US$ 29.37
US$ 25.12
US$ 22.40
US$ 24.34
US$ 25.10
